GlassScriptPrepare for your visit
Gaurav Goyal
Hematology & Oncology · Birmingham, AL · NPI 1346681772
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$40,036.97
in general payments reported to CMS, 2019-2025 · $10K in 2025
The $10K reported for 2025 was more than what 89% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Who reported paying
General payments only, top 6 by amount.
- Recordati_rare_diseases_inc. $17,387.12
- Seagen INC. $10,591.06
- Sobi, INC $9,575.83
- Pharmaessentia USA Corporation $1,500.00
- Alnylam Pharmaceuticals INC. $347.04
- Genentech, INC. $177.45
Drugs and devices associated with these payments
Sylvant Adcetris Gamifant Besremi Mi Cancer Seek
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Gaurav Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/196843/gaurav-goyal